MedMira Inc
- LAST PRICE0.0750
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0800 / 0.0750
- Day Range
- 52 Week Range
- Volume65,000
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MIR |
|---|---|---|
| 03:14 ET | 64000 | 0.075 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
MedMira Inc | 57.7M | -16.9x | --- |
Theralase Technologies Inc | 63.6M | -14.9x | --- |
Cannabix Technologies Inc | 47.2M | -12.3x | --- |
Perimeter Medical Imaging AI Inc | 61.6M | -1.9x | --- |
Treatment.com AI Inc | 26.5M | -2.3x | --- |
VentriPoint Diagnostics Ltd | 22.6M | -4.1x | --- |
Company Information
MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.
Contact Information
- Headquarters
- 155 Chain Lake Dr.,, Suite 1HALIFAX, NS, Canada B3S 1B3
- Phone
- 902-450-1588
- Fax
- 902-450-1580
Executives
- Independent Chairman of the Board
- Thomas Bergmann
- Chief Executive Officer, Director
- Hermes Chan
- Chief Financial Officer
- Markus Meile
- Independent Director
- Steven Cummings
- Independent Director
- Jianhe Mao
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $54.1M |
|---|---|
Revenue (TTM) | $383.3K |
Shares Outstanding | 720.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $0.00 |
Book Value | $-0.02 |
P/E Ratio | -16.9x |
Price/Sales (TTM) | 141.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -525.29% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
